Tech Company Financing Transactions
Vedanta Biosciences Funding Round
On 6/7/2016, Vedanta Biosciences announced $50 million in funding from INVESCO Private Capital, Rock Springs Capital and private investors.
Transaction Overview
Company Name
Announced On
6/7/2016
Transaction Type
Venture Equity
Amount
$50,000,000
Round
Undisclosed
Proceeds Purpose
Proceeds from the financing will be used to advance multiple clinical studies in infectious and autoimmune diseases and to scale the company's technology platform.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
19 Blackstone St.
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Website
Email Address
Overview
Vedanta Biosciences was founded by PureTech and a team of world renowned experts in immunology and microbiology. Vedanta Biosciences is developing a class of drugs that work by modulating the human microbiome, with an initial emphasis in autoimmune and inflammatory diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Bernat Olle
Chief Financial Officer
Mark Mullikin
Chief Medical Officer
Jeffrey Silber
Chief Operating Officer
Daniel Couto
VP - Bus. Development
Taylor Feehley
VP - Finance
Maggie McGuigan
VP - Human Resources
Jack Kyte
VP - Manufacturing
Kris Ireland
VP - Operations
Lorraine Hughes
VP - Operations
Debra Winslow
VP - Regulatory Affairs
Anne Kuan
VP - Regulatory Affairs
Thomas O'Brien
Browse more venture capital transactions:
Prev: 6/7/2016: Recharge venture capital transaction
Next: 6/7/2016: Figure Eight venture capital transaction
Share this article
About Database of VC Transactions
We do our best to record tech company VC transactions. VC investment data records reported here are derived from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs